Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomized, Double-blind, Placebo (Vehicle)-Controlled, Dose Finding Trial to Assess the Safety, Tolerability and Efficacy of NRD135S.E1 in Patients With Neuropathic Pain Associated With Diabetes Mellitus

NCT02345291 is registered in ClinicalTrials.gov with Novaremed Ltd. as lead sponsor.

NCT NCT02345291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02345291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomized, Double-blind, Placebo (Vehicle)-Controlled, Dose Finding Trial to Assess the Safety, Tolerability and Efficacy of NRD135S.E1 in Patients With Neuropathic Pain Associated With Diabetes Mellitus
Lead sponsor
Novaremed Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
July 31, 2016
Enrollment
88 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain